Colon cancer is no longer just an older person’s disease, and the numbers prove it.
Quick Take
- Major health groups lowered the recommended colorectal cancer screening age to 45, five years earlier than before.
- Incidence in adults under 50 has nearly doubled since the early 1990s, rising from 8.6 to 12.9 cases per 100,000 people.
- Younger patients often wait longer for a diagnosis because doctors first look for other, more common causes of their symptoms.
- Guidelines still say average-risk adults under 45 don’t need routine screening, since risk at that age remains comparatively low.
Why Health Groups Moved the Screening Age Down
The Centers for Disease Control and Prevention (CDC) now tells most people to start colorectal cancer screening at age 45, not 50. The U.S. Preventive Services Task Force made that same call in 2021, saying adults 45 to 49 get a “moderate net benefit” from screening. The American Cancer Society made the shift first, back in 2018, after reviewing data that showed something alarming in younger adults.
That alarming data was a steady climb in cases among people who hadn’t hit 50 yet. Research tracking national cancer statistics found incidence in adults under 50 nearly doubled since the early 1990s, climbing from 8.6 to 12.9 cases per 100,000 people. Younger adults now make up 10 to 12 percent of all colorectal cancer diagnoses in the United States. That’s a meaningful slice of a disease once considered a problem for retirees.
Health and Human Services Secretary Robert F. Kennedy Jr. has put a spotlight on the trend, pointing to ultra-processed foods as a possible driver behind the rising case counts in young Americans. Whatever the exact cause turns out to be, the underlying statistics he’s referencing come from the same registry data cancer groups have been tracking for years.
Why Younger Patients Often Get Diagnosed Later
Age isn’t the only problem. Several studies on diagnostic delay found younger colorectal cancer patients often wait longer for answers than older patients do. A systematic review of multiple studies found 14 of them showed significantly longer delays for younger adults before diagnosis, compared to only nine showing shorter delays. One review pointed to a specific reason: age-based screening rules combined with doctors misreading symptoms as something less serious, which pushes diagnosis to a later, more advanced stage.
A separate study on young adults with colorectal cancer found they are often diagnosed at a more advanced stage than older patients, likely tied to these diagnostic delays. Researchers writing in the journal Frontiers in Oncology have proposed a specific fix: patients younger than the screening age who show warning signs like rectal bleeding, unexplained anemia, ongoing belly pain, or changed bowel habits should get fast-tracked to a colonoscopy instead of being assumed to have a benign condition.
Where the Guidance Draws a Line
Health groups haven’t gone so far as recommending screening for every adult under 45. The American Cancer Society specifically decided not to push the screening age lower than 45 for people at average risk, because cases in the 40-to-44 age group remain less than half the rate seen in the 45-to-49 group. That distinction matters. It means the science supports earlier screening at 45, but it doesn’t support treating every younger adult as high-risk by default.
The takeaway for readers over 40 is straightforward. If you’re 45 or older, get screened on schedule, since that’s now the mainstream medical standard, not an early outlier opinion. If you’re younger and have persistent symptoms like bleeding, anemia, or unexplained bowel changes, don’t accept a quick dismissal. Push for a real answer. The data shows younger patients who speak up and press for testing tend to catch the disease before it advances.
Colorectal cancer remains highly treatable when caught early, no matter the patient’s age. The real shift here isn’t just a new number on a screening chart. It’s a broader recognition that this disease no longer waits for a 50th birthday, and neither should the medical system’s attention to warning signs in younger patients.
Sources:
sciencedaily.com, uspreventiveservicestaskforce.org, gi.org, aafp.org, pressroom.cancer.org, cancer.org
